Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma

Journal of Clinical Oncology

Volumn 25, Issue 9, 2007, Pages 1033-1037

  Carver, Brett S ^a   Shayegan, Bobby ^a   Serio, Angel ^a   Motzer, Robert J ^a   Bosl, George J ^a   Sheinfeld, Joel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PRIORITY JOURNAL; TERATOMA; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; DISEASE FREE SURVIVAL; FOLLOW UP; KAPLAN MEIER METHOD; LYMPH NODE; LYMPHADENECTOMY; METASTASIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROPERITONEAL TUMOR; RETROPERITONEUM; RISK ASSESSMENT; TESTIS TUMOR; TIME; UNITED STATES;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; MALE; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NEW YORK CITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROPERITONEAL NEOPLASMS; RETROPERITONEAL SPACE; RISK ASSESSMENT; TERATOMA; TESTICULAR NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34047226933     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.4791     Document Type: Article

References (17)

1. Sheinfeld J, Herr HW: Role of surgery in management of germ cell tumor. Semin Oncol 25: 203-209, 1998
2. Toner GC, Panicek DM, Heelan RT, et al: Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: Recommendations for patient selection. J Clin Oncol 8:1683-1694, 1990
3. Steyerberg EW, Keizer HJ, Fossa SD, et al: Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: Multivariate analysis of individual patient data from six study groups. J Clin Oncol 13:1177-1187, 1995
4. Aass N, Klepp O, Cavallin-Stahl E, et al: Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: A multicenter experience. J Clin Oncol 9:818-826, 1991
5. Fossa SD, Ovist H, Stenwig AE, et al: Is post-chemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? J Clin Oncol 10:569-573, 1992
6. Motzer RJ, Amsterdam A, Prieto V, et al: Teratoma with malignant transformation: Diverse malignant histologies arising in men with germ cell tumors. J Urol 159:133-138, 1998
7. Baniel J, Foster RS, Gonin R, et al: Late relapse of testicular cancer. J Clin Oncol 13:1170-1176, 1995
8. Donohue JP, Roth LM, Zachary JM, et al: Cytoreductive surgery for metastatic testis cancer: Tissue analysis of retroperitoneal masses after chemotherapy. J Urol 127:1111-1114, 1982
9. Fossa SD, Aass N, Ous S, et al: Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. J Urol 142:1239-1242, 1989
10. Loehrer PJ, Hui S, Clark S, et al: Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: A clinicopathological correlation. J Urol 135:1183-1189, 1986
11. Sonneveld DJ, Sleifer DT, Koops HS, et al: Mature teratoma identified after post-chemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors. Cancer 82: 1343-1351, 1998
12. Dieckmann KP, Albers P, Classen J, et al: Late relapse of testicular germ cell neoplasms: A descriptive analysis of 122 cases. J Urol 173:824-829, 2005
13. George DW, Foster RS, Hromas RA, et al: Update on late relapse of germ cell tumor: A clinical and molecular analysis. J Clin Oncol 21:113-122, 2003
14. McKiernan JM, Motzer RJ, Bajorin DF, et al: Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: Clinical presentation, patterns of recurrence, and outcome. Urology 62:732-736, 2003
15. International Germ Cell Cancer Collaborative Group: International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594-603, 1997
16. Comiter CV, Kibel AS, Richie JP, et al: Prognostic features of teratomas with malignant transformation: A clinicopathological study of 21 cases. J Urol 159:859-863, 1998
17. Donadio AC, Motzer RJ, Bajorin DF, et al: Chemotherapy for teratoma with malignant transformation. J Clin Oncol 21:4285-4291, 2003